Lastly, B-MYB was also shown to bind to the MYCN promoter in chromatin-IP assays of MYCN amplified neuroblastoma cells in culture, and induced a relatively modest transcriptional upregulation of a MYCN promoter element. The gene discussed is MYCN; the disease is neuroblastoma.